STK11 genotyping and cancer risk in Peutz-Jeghers syndrome
The estimated relative cancer risk may be 15 fold higher than in the general population 1 and appears to be particularly high in women (20 fold) because of an increased risk of development of breast cancer and gynaecological malignancies. 2 Germline mutations in the STK11/LKB1 gene on 19p13.3 are fo...
Saved in:
Published in | Journal of medical genetics Vol. 42; no. 5; pp. 428 - 435 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd
01.05.2005
BMJ BMJ Publishing Group LTD BMJ Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The estimated relative cancer risk may be 15 fold higher than in the general population 1 and appears to be particularly high in women (20 fold) because of an increased risk of development of breast cancer and gynaecological malignancies. 2 Germline mutations in the STK11/LKB1 gene on 19p13.3 are found in 30-70% of PJS cases, depending on the screening method, with considerable uncharacterised genetic heterogeneity remaining in this syndrome. 3, 4 The disease causing gene has been identified by two independent groups. 5, 6 Human STK11 encodes a serine/threonine protein kinase that is highly homologous to the mouse protein Lkb1 and the Xenopus kinase XEEK1, 7, 8 and is expressed in all human tissues. 9 The kinase domain of the human 433 amino acid protein is localised between residues 49 and 309, 7 and shows homology to the conserved catalytic core of the kinase domain common to both serine/threonine and tyrosine protein kinase family members. 10 Most mutations found in PJS patients are small deletions/insertions or single base substitutions leading to an abnormal truncated/kinase inactive protein. PJS is a cancer predisposing disorder; however, cancer risk may vary. [...]we studied whether specific STK11 mutations may confer a lower or higher cancer risk in PJS patients by examining the site and type of mutations with regard to cancer frequency and cancer type. |
---|---|
Bibliography: | ark:/67375/NVC-05MT7TSQ-S local:0420428 PMID:15863673 href:jmedgenet-42-428.pdf Correspondence to: Dr. Valérie Schumacher Heinrich-Heine Universitaet Düsseldorf, Institut für Humangenetik und Anthropologie, Universitaetsstrasse 1, D-40225 Düsseldorf; schumacv@uni-duesseldorf.de istex:D0A21E18B79525CBC290B7C821F5D7B8AECC5649 SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 0022-2593 1468-6244 1468-6244 |
DOI: | 10.1136/jmg.2004.026294 |